While the use of S100 in cutaneous melanoma is well established, there is scarce and inconclusive evidence on the performance of S100 protein as a serum tumor marker in advanced uveal melanoma: while some studies suggest a link with tumor burden [20,21,22,23], Strobel et al. question its value and sensitivity [24]. This evidence concerns the gene S100B and cutaneous melanoma.